THE RADIOBIOLOGICAL PLATFORM AT ARRONAX.


Journal

Radiation protection dosimetry
ISSN: 1742-3406
Titre abrégé: Radiat Prot Dosimetry
Pays: England
ID NLM: 8109958

Informations de publication

Date de publication:
01 May 2019
Historique:
received: 24 12 2018
pubmed: 23 1 2019
medline: 5 6 2019
entrez: 23 1 2019
Statut: ppublish

Résumé

The cyclotron ARRONAX can deliver different types of particles (protons, deuterons, alpha-particles) in an energy range up to 68 MeV. One of its six experimental halls is dedicated to studying the interactions of radiation with matter including living matter. A horizontal beamline for cell irradiation has been setup and characterized. The radiobiological characterization was done in terms of V79 cells survival after irradiation with 68 MeV protons. The results demonstrate that radiobiological studies can be successfully performed confirming the high potential of the facility.

Identifiants

pubmed: 30668799
pii: 5298230
doi: 10.1093/rpd/ncy301
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

270-273

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Charbel Koumeir (C)

GIP ARRONAX, Saint-Herblain, France.

Viviana De Nadal (V)

Laboratori Nazionali di Legnaro INFN, Legnaro-Padova, Italy.

Roberto Cherubini (R)

Laboratori Nazionali di Legnaro INFN, Legnaro-Padova, Italy.

Michel Cherel (M)

INSERM, CRCINA, Nantes, France.

Eric Garrido (E)

Laboratoire de Physique Corpusculaire de Caen, France.

Sébastien Gouard (S)

INSERM, CRCINA, Nantes, France.

Arnaud Guertin (A)

Laboratoire SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes, France.

Ferid Haddad (F)

GIP ARRONAX, Saint-Herblain, France.
Laboratoire SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes, France.

Vincent Métivier (V)

Laboratoire SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes, France.

Nathalie Michel (N)

GIP ARRONAX, Saint-Herblain, France.

Freddy Poirier (F)

GIP ARRONAX, Saint-Herblain, France.

Noel Servagent (N)

Laboratoire SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes, France.

Thomas Sounalet (T)

Laboratoire SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes, France.

Nicolas Varmenot (N)

INSERM, CRCINA, Nantes, France.
Institut de Cancérologie de l'Ouest, Saint-Herblain, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH